Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypericin--the facts about a controversial agent.

A Kubin1, F Wierrani, U Burner

  • 1Ludwig Boltzmann Institute for Clinical Oncology and Photodynamic Therapy, Erlgasse 48, 1120 Vienna, Austria. akubin@planta.at

Current Pharmaceutical Design
|January 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On De Giorgi's conjecture of nonlocal approximations for free-discontinuity problems: The symmetric gradient case.

Calculus of variations and partial differential equations·2026
Same author

[Treatment of Chronic Functional Constipation during Pregnancy and Lactation].

Zeitschrift fur Geburtshilfe und Neonatologie·2016
Same author

Computerized in vivo classification of methylene blue stained fallopian tube mucosal damage: preliminary results.

Clinical and experimental obstetrics & gynecology·2014
Same author

Maternal sepsis due to Clostridium perfringens after 2nd-trimester genetic amniocentesis.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2011
Same author

Fabric-mechanical property relationships of trabecular bone allografts are altered by supercritical CO₂ treatment and gamma sterilization.

Bone·2011
Same author

How to make hypericin water-soluble.

Die Pharmazie·2008
Same journal

Role of Phenolic Nanocompounds in Inflammatory Disorders: Current View and Future Aspects.

Current pharmaceutical design·2026
Same journal

Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.

Current pharmaceutical design·2026
Same journal

Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.

Current pharmaceutical design·2026
Same journal

Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.

Current pharmaceutical design·2026
Same journal

Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

Current pharmaceutical design·2026
Same journal

Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.

Current pharmaceutical design·2026
See all related articles

Hypericin, a compound from St. John's Wort, shows potential in treating depression, cancer, and viral infections. Further research is needed to confirm its mechanisms and therapeutic applications.

Area of Science:

  • Natural Products Chemistry
  • Pharmacology
  • Biochemistry

Background:

  • Hypericin is a natural compound from St. John's Wort (Hypericum species) with a history in folk medicine.
  • It is increasingly recognized for its multifunctional therapeutic potential in drug and medicinal applications.
  • Research highlights its traditional use and growing scientific interest over the past three decades.

Purpose of the Study:

  • To summarize current research on hypericin's diverse biological activities and therapeutic potential.
  • To explore its applications in various medical fields, including antidepressive, antineoplastic, and antiviral therapies.
  • To contribute to the ongoing discussion and re-evaluation of hypericin's medical significance.

Main Methods:

  • Review of recent biochemical and pharmacological studies on hypericin.

Related Experiment Videos

  • Screening of hypericin for inhibitory effects on key enzymes like MAO, PKC, and CYP450.
  • Investigation of hypericin's effects on GABA-activated currents and NMDA receptors.
  • Exploration of its role in photochemistry and photobiology for cancer treatment and diagnostics.

    • Main Results:

    • Hypericin exhibits promising antidepressive, antineoplastic, antitumor, and antiviral (HIV, HCV) activities.
    • It inhibits important enzymes (MAO, PKC, CYP450, reverse transcriptase, telomerase) and modulates neurotransmitter receptors (GABA, NMDA).
    • Its potential as a therapeutic and diagnostic agent in cancer via photodynamic therapy is under investigation.

    Conclusions:

    • Hypericin demonstrates significant therapeutic potential across multiple medical domains.
    • Further research is essential to validate its efficacy, elucidate mechanisms, and address controversial findings.
    • Hypericin is emerging as a promising agent for novel diagnostic and therapeutic applications.